Rendering of a Local 1g Environment for Enhanced Motor Learning in Altered Gravity
NCT ID: NCT03978910
Last Updated: 2019-06-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
18 participants
INTERVENTIONAL
2019-04-01
2021-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
THE INFLUENCE OF GRAVITY
NCT03298139
Influence of Gravity on Dexterity, Hand-eye Coordination and Perception of Orientation and Distances
NCT02563249
Evaluation of Motor Learning on a Sequence of Manual Motor Gestures of Increasing Complexity Through the Mental Practise
NCT03769974
Body-environment Relationship Related Modified Gravity
NCT05531162
Examining Lateralized Aspects of Motor Control Using Non-invasive Neural Stimulation
NCT05947279
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Weigthlessness
during a flight
measurements of the accuracy of the reaching movements
Euclidian distance between final position and target
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
measurements of the accuracy of the reaching movements
Euclidian distance between final position and target
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged from 18 to 65.
* Affiliated to a Social Security system and, for non-French resident, holding a European Health Insurance Card (EHIC).
* Who accepted to take part in the study.
* Who can take scopolamine or nautamine (medication against airsickness).
* Who have given their informed written stated consent.
* Who have passed a medical examination similar to a standard aviation medical examination for private pilot aptitude (JAR FCL3 Class 2 medical examination) and have been declared fit to fly. The examination must be less than one year before the experiment flight. There will be no additional test performed for participant selection.
Exclusion Criteria
* Persons with any history of cerebral, cardiovascular or vestibular diseases.
* Persons with history of psychiatric diseases, including anxiety disorder.
* Persons whose medical condition has changed since the class 2-like medical examination.
* Pregnant women (urine pregnancy test for women of childbearing potential).
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Caen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Caen Univerity Hospital
Caen, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Stephane BESNARD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18-210
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.